ZLAB Stock: Price, Earnings History and SEC Filings
Zai Lab Limited (ZLAB) last traded at $22.07, down 1.30% on the latest session and down 16.2% over the past month. In its most recent reported quarter (Mar 2026) earnings per share were $-0.46 against an analyst estimate of $-0.58, a beat of 20.7%.
$22.07 -1.30%
1 month-16.21%
52-week high$27.50
52-week low$15.96
Volume637,839
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ZLAB earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Mar 2026 | May 7, 2026 | $-0.46 | $-0.58 | +20.69% |
| Dec 2025 | Feb 26, 2026 | $-0.46 | $-0.44 | -4.55% |
| Sep 2025 | Nov 6, 2025 | $-0.33 | $-0.28 | -17.86% |
ZLAB beat the analyst EPS estimate in 1 of its last 3 reported quarters. Source: Nasdaq.
Latest SEC filings for ZLAB
SEC filing data is not available right now. You can search for ZLAB on SEC EDGAR.
ZLAB news
- Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingOct 27, 2026 · finance.yahoo.com
- Asian Equities Traded in the US as American Depositary Receipts Decline in Friday TradingOct 23, 2026 · finance.yahoo.com
- Zai Lab’s Zoci Shows 82% Response Rate in Early Lung Cancer StudyOct 23, 2026 · marketbeat.com
- Zai Lab's Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung CancerOct 23, 2026 · finance.yahoo.com
- Zai Lab Says Zoci Plus Atezolizumab Improves Response Rate in Phase 1 Lung Cancer TrialOct 23, 2026 · finance.yahoo.com
- Zai Lab Announces $250 Million Private PlacementOct 23, 2026 · finance.yahoo.com
- Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday TradingOct 22, 2026 · finance.yahoo.com
- Zai Lab to Announce Third Quarter 2026 Financial Results and Recent Corporate Updates on November 5, 2026Oct 21, 2026 · finance.yahoo.com
About Zai Lab Limited
Zai Lab Limited (ZLAB) is a US-listed public company on Nasdaq.